Coming months critical for Mirena Pseudotumor Plaintiffs
Coming months critical for Mirena Pseudotumor Plaintiffs
Introduction
Mirena lawsuits' MDL 2767 linked to intracranial hypertension also called pseudotumor cerebri were centralized in April 2017 before Judge Paul A. Engelmayer in the U.S. District Court for the Southern District of New York. This MDL is moving forward speedily. With the first phase of discovery initiated, depositions are taking place proving to be a critical time for the plaintiffs. The defendant, Bayer, continues to maintain that its Mirena is a safe and effective method of birth control. The Daubert Hearings are scheduled to begin early 2018.
Comments
Latest News
First Federal Bellwether Trial Set in Strattice Mesh Case
Categories: Hernia Mesh
Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…
Tepezza Hearing Loss Trial Set for June 2026
Categories: Tepezza
The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.
This decision comes as attorneys…
FDA Moves to Restrict Dangerous 7-OH Opioid Products
Categories: Opioids
In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…